American International Group’s Y-mAbs Therapeutics YMAB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-18,132
| Closed | -$295K | – | 2788 |
|
2024
Q1 | $295K | Sell |
18,132
-155
| -0.8% | -$2.52K | ﹤0.01% | 1926 |
|
2023
Q4 | $125K | Sell |
18,287
-74
| -0.4% | -$505 | ﹤0.01% | 2435 |
|
2023
Q3 | $100K | Buy |
18,361
+653
| +4% | +$3.56K | ﹤0.01% | 2512 |
|
2023
Q2 | $120K | Sell |
17,708
-12
| -0.1% | -$81 | ﹤0.01% | 2462 |
|
2023
Q1 | $88.8K | Buy |
17,720
+354
| +2% | +$1.77K | ﹤0.01% | 2515 |
|
2022
Q4 | $84.7K | Sell |
17,366
-64
| -0.4% | -$312 | ﹤0.01% | 2583 |
|
2022
Q3 | $251K | Buy |
17,430
+246
| +1% | +$3.54K | ﹤0.01% | 2031 |
|
2022
Q2 | $260K | Sell |
17,184
-166
| -1% | -$2.51K | ﹤0.01% | 2016 |
|
2022
Q1 | $206K | Sell |
17,350
-1,222
| -7% | -$14.5K | ﹤0.01% | 2218 |
|
2021
Q4 | $301K | Sell |
18,572
-556
| -3% | -$9.01K | ﹤0.01% | 2118 |
|
2021
Q3 | $546K | Sell |
19,128
-454
| -2% | -$13K | ﹤0.01% | 1793 |
|
2021
Q2 | $662 | Buy |
19,582
+1,799
| +10% | +$61 | ﹤0.01% | 1759 |
|
2021
Q1 | $538 | Buy |
17,783
+47
| +0.3% | +$1 | ﹤0.01% | 1795 |
|
2020
Q4 | $878 | Sell |
17,736
-169
| -0.9% | -$8 | ﹤0.01% | 1458 |
|
2020
Q3 | $687K | Sell |
17,905
-406
| -2% | -$15.6K | ﹤0.01% | 1433 |
|
2020
Q2 | $791K | Buy |
18,311
+4,316
| +31% | +$186K | ﹤0.01% | 1347 |
|
2020
Q1 | $365K | Sell |
13,995
-810
| -5% | -$21.1K | ﹤0.01% | 1579 |
|
2019
Q4 | $463K | Buy |
14,805
+1,955
| +15% | +$61.1K | ﹤0.01% | 1730 |
|
2019
Q3 | $335K | Sell |
12,850
-89
| -0.7% | -$2.32K | ﹤0.01% | 1873 |
|
2019
Q2 | $296K | Buy |
12,939
+8,498
| +191% | +$194K | ﹤0.01% | 2001 |
|
2019
Q1 | $116K | Sell |
4,441
-144
| -3% | -$3.76K | ﹤0.01% | 2543 |
|
2018
Q4 | $93K | Buy |
+4,585
| New | +$93K | ﹤0.01% | 2635 |
|